AMGEN INC 8-K

What Happened

• On April 30, 2026, Amgen Inc. (AMGN) announced its unaudited results for the quarter ended March 31, 2026 and its financial position as of March 31, 2026 via a press release furnished as Exhibit 99.1 to an 8‑K (Item 2.02). The release includes GAAP results plus a suite of non‑GAAP financial measures and reconciliations to the most directly comparable GAAP measures.
• Amgen presented non‑GAAP metrics including non‑GAAP earnings per share, non‑GAAP operating income and margin, non‑GAAP tax rate, and non‑GAAP operating expenses with subcomponents (non‑GAAP cost of sales, R&D, and SG&A). The company also disclosed Free Cash Flow (FCF = operating cash flow minus capital expenditures) and explained the exclusions used to calculate non‑GAAP amounts (acquisition‑related charges, restructuring/cost‑savings charges, certain investment gains/losses and legal items), plus the tax treatment of those adjustments. The filing is signed by Peter H. Griffith, Executive VP and CFO, and the press release is furnished (not “filed”) under Section 18.

Key Details

• Filing date: April 30, 2026; reporting period: three months ended March 31, 2026 (balance sheet as of March 31, 2026).
• Non‑GAAP measures included: non‑GAAP EPS, operating income, operating margin, tax rate, operating expenses (with cost of sales, R&D, SG&A broken out).
• Free Cash Flow defined and disclosed as operating cash flow less capital expenditures (GAAP‑based components).
• Reconciliations from GAAP to each non‑GAAP measure are included in the press release (Exhibit 99.1).

Why It Matters

• Investors get Amgen’s Q1 2026 quarterly results and the company’s view of underlying performance using non‑GAAP measures, plus reconciliations to GAAP. That helps analysts compare ongoing operating results across periods by excluding acquisition, restructuring and other one‑time items that Amgen says can distort comparisons.
• Free Cash Flow disclosure gives a GAAP‑based view of liquidity after capital spending, relevant for assessing cash available for dividends, buybacks, debt repayment or investments.
• Note: the company stresses non‑GAAP measures are supplemental—not a substitute for GAAP—and the press release is furnished (limiting certain Section 18 liabilities).